4//SEC Filing
Reed Joshua 4
Accession 0000899243-22-034463
CIK 0001850838other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 6:36 PM ET
Size
5.6 KB
Accession
0000899243-22-034463
Insider Transaction Report
Form 4
Reed Joshua
Chief Financial Officer
Transactions
- Award
Option (Right to Buy)
2022-10-27+55,000→ 55,000 totalExercise: $5.27Exp: 2032-10-26→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001746541
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 6:36 PM ET
- Size
- 5.6 KB